PSR Launches New Service for Companies Planning Orphan Drug Development, OrphanIQ |
| Print | |
| Monday, 05 July 2010 11:00 (UTC + 2) |
|
Hoofddorp, The Netherlands, July 5, 2010 / b3c newswire / – PSR announced today the launch of its new service and dedicated website, OrphanIQ™. OrphanIQ™ is a quick and easy way for companies involved in Orphan Drug development to ask a short question on a variety of topics without the need for setting up time-consuming agreements and contracts. Questions will be handled by the relevant expert, who will first assess whether the question can be answered without obtaining further information, and within a reasonable time-frame, and will subsequently provide a written answer.
“The launch of this service is part of PSR’s continuous strategy to provide expert services for Orphan Drug development in an innovative way,” said Dr Roger Legtenberg, General Manager, PSR. “The need for this service shows that, even in the non-standard environment that is Orphan Drug Development, practical and quick solutions can be provided for pharmaceutical and biotech companies, without having to put in heavy upfront investments.”
About PSR - http://www.psr-group.com/clinical.php
OrphanIQ™: http://www.orphan-IQ.com
For more information:
Tel: +31 23 556 3220
Dr Anthony Hall,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
